Antivirals

Cards (17)

  • Classification of drugs
    • Antiviral drugs
    • Antiretroviral drugs
  • Antiviral drugs
    Used to treat infections caused by viruses other than HIV
  • Antiretroviral drugs
    Used to treat infections caused by HIV, the virus that causes AIDS
  • Viruses controlled by antiviral therapy
    • Cytomegalovirus (CMV)
    • Hepatitis viruses (A, B, C)
    • Herpes viruses (HSV-1, HSV-2)
    • Human immunodeficiency virus (HIV)
    • Influenza viruses
    • Respiratory syncytial virus (RSV)
    • Varicella zoster virus (Chickenpox, Shingles)
  • Antiviral Drugs
    • Inhibit viral replication
    • Used to treat non-HIV viral infections
  • Non-HIV viral infections treated by antiviral drugs
    • Influenza viruses
    • HSV (herpes simplex virus)
    • VZV (varicella zoster virus)
    • CMV (cytomegalovirus)
    • Hepatitis A, B, C (HAV, HBV, NCV)
  • Adverse Effects of antiviral drugs
    Vary with each drug<|>Healthy cells are often killed also, resulting in serious toxicities
  • Amantadine
    • Narrow antiviral spectrum−active only against influenza A
    • Used prophylactically when vaccine is not available or cannot be given
    • Therapeutic use can reduce recovery time
    • CNS effects: insomnia, nervousness, lightheadedness
    • GI effects: anorexia, nausea, others
  • Rimantadine
    • Same spectrum of activity, mechanism of action, and indications as amantadine
    • Fewer CNS adverse effects
    • Causes GI upset
  • Acyclovir
    • Synthetic nucleoside analog
    • Used to suppress replication of HSV-1, HSV-2, VZV
    • Drug of choice for treatment of initial and recurrent episodes of these infections
    • Oral, topical, parenteral forms
  • Ganciclovir
    • Synthetic nucleoside analog
    • Used to treat infection with cytomegalovirus (CMV)
    • Oral, parenteral forms
    • CMV retinitis: ophthalmic form surgically implanted, ocular injection (fomivirsen)
  • Dose-Limiting Toxicities
    • ganciclovir
    • zidovudine
  • Dose-Limiting Toxicities
    Bone marrow toxicity
  • Neuraminidase Inhibitors
    • Oseltamivir and zanamivir
    • Active against influenza types A & B
    • Use: Reduce duration of illness
  • Oseltamivir
    • Causes nausea & vomiting
  • Zanamivir
    • Causes diarrhea, nausea, sinusitis
  • Treatment should begin within 2 days of influenza symptom onset